Corteva, Inc. $CTVA Stake Lowered by Aristotle Capital Management LLC

Key Points

• Aristotle Capital Management trimmed its position in Corteva by 4.4% in Q3, selling 972,316 shares and now holds 21,041,806 shares (3.11% of the company) valued at about $1.423 billion, making CTVA its fifth-largest holding.
• Q4 results and guidance: Corteva reported $0.22 EPS (in line with estimates) but revenue of $3.91 billion missed the $4.23 billion consensus and was down 1.7% YoY; the company set FY2026 guidance of $3.45–$3.70 EPS while sell‑side analysts expect roughly $2.96 for the current year.
• Dividend, valuation and ownership: Corteva pays a $0.18 quarterly dividend (annualized $0.72, yield ~0.9%), trades at a PE of about 50 with a $53.2 billion market cap, has ~81.5% institutional ownership, and recently saw insider Brian Titus sell shares.

Aristotle Capital Management LLC trimmed its position in shares of Corteva, Inc. (NYSE:CTVA - Free Report) by 4.4% during the 3rd quarter, according to its most recent 13F filing with the SEC. The fund owned 21,041,806 shares of the company's stock after selling 972,316 shares during the quarter. Corteva comprises about 2.7% of Aristotle Capital Management LLC's holdings, making the stock its 5th biggest holding. Aristotle Capital Management LLC owned 3.11% of Corteva worth $1,423,062,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also bought and sold shares of the company. Chilton Capital Management LLC increased its stake in shares of Corteva by 18.1% in the 3rd quarter. Chilton Capital Management LLC now owns 445,350 shares of the company's stock worth $30,119,000 after purchasing an additional 68,380 shares in the last quarter. TriaGen Wealth Management LLC bought a new position in shares of Corteva in the third quarter worth about $4,284,000. Truist Financial Corp lifted its position in shares of Corteva by 4.5% during the 3rd quarter. Truist Financial Corp now owns 321,913 shares of the company's stock valued at $21,771,000 after buying an additional 13,910 shares in the last quarter. New York State Teachers Retirement System increased its holdings in Corteva by 4.5% in the 3rd quarter. New York State Teachers Retirement System now owns 551,389 shares of the company's stock worth $37,290,000 after acquiring an additional 23,548 shares in the last quarter. Finally, Alberta Investment Management Corp bought a new stake in Corteva during the 3rd quarter worth approximately $5,018,000. 81.54% of the stock is currently owned by institutional investors.

Corteva Stock Performance

NYSE:CTVA opened at $79.13 on Friday. The company has a debt-to-equity ratio of 0.07, a quick ratio of 0.96 and a current ratio of 1.43. The stock's fifty day moving average is $74.11 and its 200 day moving average is $69.21. The firm has a market capitalization of $53.22 billion, a PE ratio of 50.08, a PEG ratio of 2.71 and a beta of 0.72. Corteva, Inc. has a fifty-two week low of $53.40 and a fifty-two week high of $80.90.

Corteva (NYSE:CTVA - Get Free Report) last posted its quarterly earnings data on Tuesday, February 3rd. The company reported $0.22 earnings per share for the quarter, meeting analysts' consensus estimates of $0.22. The business had revenue of $3.91 billion for the quarter, compared to analysts' expectations of $4.23 billion. Corteva had a net margin of 6.29% and a return on equity of 9.06%. The business's revenue was down 1.7% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.32 earnings per share. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. On average, sell-side analysts anticipate that Corteva, Inc. will post 2.96 earnings per share for the current year.

Corteva Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Monday, March 16th. Investors of record on Monday, March 2nd will be given a $0.18 dividend. This represents a $0.72 dividend on an annualized basis and a yield of 0.9%. The ex-dividend date of this dividend is Monday, March 2nd. Corteva's dividend payout ratio is 45.57%.

Insider Transactions at Corteva

In other Corteva news, insider Brian Titus sold 8,311 shares of the business's stock in a transaction that occurred on Friday, February 20th. The stock was sold at an average price of $76.55, for a total transaction of $636,207.05. Following the completion of the transaction, the insider owned 8,090 shares in the company, valued at $619,289.50. The trade was a 50.67% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. 0.14% of the stock is currently owned by insiders.

Analyst Ratings Changes

Several research analysts recently weighed in on the stock. Argus raised shares of Corteva to a "strong-buy" rating in a report on Friday, January 16th. Mizuho raised their price target on Corteva from $80.00 to $82.00 and gave the company an "outperform" rating in a report on Tuesday, February 17th. BNP Paribas Exane upped their price objective on Corteva from $72.00 to $74.00 in a research note on Monday, March 9th. JPMorgan Chase & Co. cut Corteva from an "overweight" rating to a "neutral" rating and increased their target price for the stock from $75.00 to $77.00 in a research report on Thursday, February 5th. Finally, Zacks Research downgraded Corteva from a "strong-buy" rating to a "hold" rating in a research note on Friday, February 20th. One research analyst has rated the stock with a Strong Buy rating, thirteen have given a Buy rating and eight have issued a Hold rating to the company. Based on data from MarketBeat, Corteva presently has an average rating of "Moderate Buy" and an average target price of $82.90.

About Corteva

Corteva, Inc NYSE: CTVA is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva's operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.

Want to see what other hedge funds are holding CTVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Corteva, Inc. (NYSE:CTVA - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.